Oct 1, 2012
By:
Stephanie Sutton
The European Medicines Agency has updated its guidance on biosimilar medicines, with the aim of helping companies to avoid unnecessary repetition of clinical trials.
|
Sep 25, 2012
By:
Stephanie Sutton
The European Medicines Agency (EMA) has abolished its Cell-based Product Working Party (CPWP) and Gene Therapy Working Party (GTWP), with the aim of improving efficiencies and optimising the use of available expertise.
|
Sep 19, 2012
By:
Stephanie Sutton
Johnson & Johnson has announced plans to open four innovation centers in California, Boston, London and China, with the aim of accelerating early innovation and facilitating collaboration and investment opportunities.
|
Sep 18, 2012
By:
Stephanie Sutton
The European Generic Medicines Association (EGA) has raised concerns about the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities
|
Sep 10, 2012
By:
Stephanie Sutton
Eli Lilly has received an FDA Warning Letter because of a "misleading" image of a multicoloured brain that appeared on the company’s website for the diagnostic PET tracer, Amyvid.
|
Sep 5, 2012
By:
Stephanie Sutton
Merck KGaA has announced plans to eliminate 1100 jobs in Germany by the end of 2015—almost 10% of the company's 10,900 German positions.
|
Sep 3, 2012
By:
Stephanie Sutton
The European Medicines Agency has launched a public consultation concerning its inventory of paediatric medicines with the aim of highlighting where further R&D efforts are required. The consultation is the first of its kind in this area.
|
Aug 29, 2012
By:
Stephanie Sutton
The European Medicines Agency has recommended that the anticancer medicine DepoCyte be recalled from EU countries following the discovery of manufacturing deficiencies at Pacira Pharmaceuticals' San Diego site.
|
Aug 22, 2012
By:
Stephanie Sutton
GlaxoSmithKline (GSK) is selling the majority of its 'classic brands' in Australia to Aspen Global for approximately £172 million ($271.1 million) in cash.
|
|
